European Pharmaceutical Review
JULY 25, 2023
A compound annual growth rate (CAGR) growth of 5.9 The small molecule API market is influenced by several factors, including heightened R&D within the pharmaceutical sector, a growing prevalence of chronic illnesses and rising demand for generic medicines. This is a rise from $162.8 billion in 2022.
pharmaphorum
OCTOBER 11, 2022
Talking through their generic medicines, of which the company has more than 1,000 projects ongoing, Schultz noted that more than half of the leading medicines on the WHO’s list of medicines are Teva’s. Indeed, of the 281 WHO-listed essential medicines, 100% of respiratory treatments are Teva’s.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
APRIL 23, 2025
Novartis chief executive Vas Narasimhan and Paul Hudson, his counterpart at Sanofi, say the European Commission should set a spending target for medicines and vaccines to “fairly reward innovation.” pays nearly three times as much for branded and generic medicines as other comparable countries, according to U.S.
pharmaphorum
MAY 26, 2022
Throughout the pandemic, the issue of vaccine hesitancy was compounded by ethnic disparities. Liam Johnstone has six years of toxicology experience working across regulators in the UK, developing expertise in medicine, consumer product and agrochemical safety whilst working at the MHRA, OPSS and HSE, respectively.
Expert insights. Personalized for you.
97 
Let's personalize your content